腹腔镜保留十二指肠胰头切除术治疗459例癌前病变、囊性肿瘤和神经内分泌肿瘤的围手术期结局:系统综述与meta分析
该系统综述与meta分析纳入19项队列研究共459例患者,评估腹腔镜保留十二指肠胰头切除术(L-DPPHRt)治疗良性及癌前胰腺肿瘤的安全性。90天死亡率为0.43%,胰瘘B/C级发生率为18.08%。与腹腔镜胰十二指肠切除术相比,L-DPPHRt手术时间更短、出血更少,差异有统计学意义。
要点
- L-DPPHRt治疗良性、癌前囊性肿瘤及>2cm的胰腺神经内分泌肿瘤安全有效
- 完全性L-DPPHRt的胰瘘B/C级发生率低于不完全性(14.06% vs 23.95%)
- 与L-PD相比,L-DPPHRt手术时间更短、估计出血量更少
核心结论
- 腹腔镜保留十二指肠胰头切除术治疗囊性肿瘤和胰腺神经内分泌肿瘤是一种低风险手术,可实现治愈。
研究设计与样本
- 系统综述与meta分析,检索Pubmed、Embase、Medline和Cochrane图书馆。
- 纳入19项队列研究共459例患者,其中6项对照试验比较129例L-DPPHRt与205例L-PD。
主要发现
- L-DPPHRt用于123例IPMN、44例MCN、98例SPN、102例SCN和59例PNET。
- 90天死亡率为2/459(0.43%),胰瘘B/C级83例(18.08%),胆瘘35例(7.62%)。
- 完全性与不完全性L-DPPHRt的胰瘘B/C级发生率分别为36/256(14.06%)和40/167(23.95%),p=0.030。
- 平均术后住院时间14.24天。
- 腹腔镜全DPPHRt的院内死亡率1/459(0.21%),再手术率9/364(2.47%),胃排空延迟14/280(5.0%),胆总管狭窄2/459(0.43%),胆总管缺血性病变2/459(0.43%)。
关键数值与推荐
- 与L-PD相比,L-DPPHRt平均手术时间239 vs 343分钟,估计出血量128 ml vs 240 ml。
- Meta分析显示手术时间SMD -1.20(95%CI -2.08至0.31),p=0.008;出血量SMD -1.77(95%CI -2.87至-0.66),p=0.002。
临床怎么用
- 对于胰腺头部的良性、癌前囊性肿瘤及>2cm的PNET,L-DPPHRt可实现治愈且风险低。
- L-DPPHRt在术中及术后早期表现优于L-PD,可作为适宜患者的保留器官术式选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With regard to laparoscopic approach, the objective arises whether standard multiorgan Whipple resection (PD) or parenchyma-sparing procedures (DPPHRt) are the most qualified surgical treatments for benign, premalignant neoplasms. METHODS: Pubmed, Embase, Medline, and Cochrane Libraries were searched for studies reporting results and late outcomes after laparoscopic DPPHRt (L-DPPHRt) and laparoscopic PD (L-PD) for benign tumors. Data of 19 cohort studies including 459 patients were assessed. Results of six controlled trials comprising 129 L-DPPHRt and 205 L-PD for benign neoplasms were compared. RESULTS: L-DPPHRt was performed for 123 IPMNs, 44 MCNs, 98 SPNs, 102 SCNs, and 59 PNETs. 90-day mortality was 2 of 459 patients (0.43%). Pancreatic fistula B/C occurred in 83 patients (18.08%) and biliary fistula in 35 patients (7.62%). Incidence of POPF B + C following complete and incomplete L-DPPHRt was 36/256 pats. (14.06%) and 40/167 pats. (23.95%) (p = 0.030), respectively. LHS was 14.24 days (mean). Laparoscopic total DPPHR unveiled very low risk of hospital mortality (1/459 pats.;0.21%), reoperation (9/364 pats.;2.47%), DGE (14/280 pats.;5.0%), CBD stenosis (2/459 pats.;0.43%), and ischemic lesion of CBD (2/459 pats.;0.43%). Comparing 129 L-DPPHRt with 205 L-PD patients revealed overall mean values of 239. vs. 343 min. for OP time and 128 ml vs. 240 ml for estimated blood loss. Meta analysis using standardized mean difference (SMD) demonstrated these differences to be significant (OP time: SMD - 1.20, 95% CI - 2.08 to 0.31; p = 0.008; blood loss: SMD - 1.77, 95% CI - 2.87 to - 0.66; p = 0.002). L-DPPHRt was associated with better intraoperative and early postoperative performance. CONCLUSIONS: Laparoscopic DPPHR for cystic neoplasms and PNETs is a low-risk procedure leading to cure of patients. L-DPPHRt accomplishes the most appropriate goals for treatment of patients with benign, premalignant, cystic neoplasms, and PNETs (> 2 cm) of the pancreatic head.
引用
- Beger HG, Yinmo Y, Mayer B, et al. Laparoscopic duodenum-preserving pancreatic head resection in 459 patients for precancerous, cystic neoplasms, and neuroendocrine tumors. Perioperative outcome: systematic review and meta-analysis. Surg Endosc. 2026. PMID: 41651957. doi:10.1007/s00464-026-12585-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。